Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor in cervical carcinoma

Histochemical Journal

Volumn 30, Issue 8, 1998, Pages 561-567

  Reichrath, Jörg ^a   Rafi, Leyla ^a   Müller, Sieglinde M ^a   Mink, Dieter ^a   Reitnauer, Karin ^a   Tilgen, Wolfgang ^a   Schmidt, Werner ^a   Friedrich, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYTOKERATIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERCALCIURIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; UTERINE CERVIX CARCINOMA; VITAMIN D DEFICIENCY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CERVIX UTERI; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KI-67 ANTIGEN; RECEPTORS, CALCITRIOL; TRANSGLUTAMINASES; UTERINE CERVICAL NEOPLASMS;

EID: 0031696050     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1003283117492     Document Type: Article

References (42)

1. 3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors. J. Cell. Biol. 111, 2385-8.
2. 3 receptors in normal human tissues. J. Clin. Endocrinol. Metab. 67, 607-13.
3. 3, receptor in target cells. Endocrinology 122, 1224-7.
4. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108, 1083-6.
5. COLSTON, K.W., BERGER, U. & COOMBES, R.C. (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1, 188-91.
6. 3, receptor turnover by dense amino acid labelling: changes during receptor up- regulation by vitamin D metabolites. Endocrinology 120, 1173-8.
7. 3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res. 54, 1458-64.
8. DRASAR, B.S. & IRVING, D. (1973) Environmental factors and cancer of the colon and breast. Br. J. Cancer 17, 167-72.
9. GARLAND, C., SHEKELLE, R.B., BARRETT-CONNOR, F., CRIQUI, M.H. & ROSSOF, A.H. (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. The Lancet 1, 307-9.
10. GERDES, J., SCHWAB, U., LEMKE, H., et al. (1982) Production of mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13-20.
11. GERDES, J., LEMKE, H., BAISCH, H., et al. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710-15.
12. GIGI-LEITNER, O., GEIGER, B., LEVY, R., et al. (1986) Cytokeratin expression in squamous metaplasia of the human uterine cervix. Differentiation 31, 191-205.
13. HAUSSLER, M.R., MANGELSDORF, D.J., KOMM, B.S., et al. (1988) Molecular biology of the vitamin D hormone. Recent Prog. Horm. Res. 44, 263-305.
14. HILLEMANNS, P., TANNOUS-KHURI, L., KOULOS, J.P., TALMAGE, D. & WRIGHT, T.C., Jr. (1992) Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Am. J. Pathol. 141, 973-80.
15. 3 and the skin: a unique application for the treatment of psoriasis. Proc. Soc. Exp. Biol. Med. 191, 246-57.
16. 3. Endocrinology 113, 1950-7.
17. 3 on growth inhibition, differentiation, and c-myc reduction in human promyelocytic leukemia cell line HL-60. Biochem. Biophys. Res. Commun. 152, 1151-7.
18. 3 signalling. Nature 355, 446-9.
19. KRISHNAN, A.V., CRAMER, S.D., BRINGHURST, F.R., et al. (1995) Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways. Endocrinology 136, 705-12.
20. 3. In: Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. Proceedings of the Tenth Workshop on Vitamin D, Strasbourg, France, 24-29 May 1997 (edited by NORMAN, A.W., BOUILLON, R. & THOMASSET, M.), pp. 583-5. Riverside: University of California.
21. LEID, M., KASTNER, P., LYONS, R., et al. (1992) Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377-95.
22. MAJEWSKI, S., SKOPINSKA, M., BOLLAG, W. & JABLONSKA, S. (1994) Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 344, 1510-11.
23. 3 receptors in normal and psoriatic skin. J. Invest. Dermatol. 97, 230-9.
24. 3. In: Vitamin D: A Pluripotent Steroid Hormone: Structural Studies Molecular Endocrinology and Clinical Applications (edited by NORMAN, A.W., BOUILLON, R. & THOMASSET, M.), pp. 644-5. New York: Walter de Gruyter.
25. NORMAN, A.W., ROTH, J. & ORCI, L. (1982) The vitamin D endocrine system: steroid metabolism, hormone receptors and biological response (calcium binding proteins). Endocrinol. Rev. 3, 331-5.
26. 3 receptor. Proc. Natl. Acad. Sci. USA 79, 7719-23.
27. 3. J. Biol. Chem. 258, 1289-92.
28. 3 receptor expression in HaCaT keratinocytes. In: Vitamin D: Gene Regulation, Structure Function Analysis and Clinical Application (edited by NORMAN, A.W., BOUILLON, R. & THOMASSET, M.), pp. 445-6. New York: Walter de Gruyter.
29. 3 (VDR) receptors in human skin. Path. Res. Pract. 192, 281-9.
30. REICHRATH, J., MÜLLER, S.M., KERBER, A., BAUM, H.P. & BAHMER, F.A. (1997) Biological effects of topical calcipotriol (MC 903) treatment in psoriatic skin. J. Am. Acad. Dermatol. 36, 19-28.
31. REMMELE, W., HILDEBRAND, U., HIENZ, H.A., KLEIN, P.J., VIERBUCHEN, M., BEHNKEN, L.J., HEICKE, B. & SCHEIDT, E. (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on estrogen receptors, lectin receptors, and barr bodies in human breast cancer. Virchows Arch. 93, 1292-7.
32. 3 potentiates the cytotoxic effect of TNF on human breast cancer cells. Mol. Cell. Endocrinol. 106, 157-62.
33. RORKE, E.A. & JACOBBERGER, J.W. (1995) Transforming growth factor-beta 1 (TGF beta 1) enhances apoptosis in human papillomavirus type 16 immortalized human ectocervical epithelial cells. Exp. Cell. Res. 216, 65-72.
34. rd Auflage, pp. 129-206. Munich: Urban u. Schwarzenberg.
35. SHOJI, Y., SAEGUSA, M., TAKANO, Y., OHBU, M. & OKAYASU, I. (1996) Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. J. Clin. Pathol. 49, 134-8.
36. 3 on the morphological and biochemical differentiation on cultured human epidermal keratinocytes grown in serum-free conditions. J. Invest. Dermatol. 86, 709-14.
37. 3 in intestinal tract stomach, kidney, skin, pituitary and parathyroid. Science 206, 1189-90.
38. TENNISWOOD, M.P., GUENETTE, S., LAKINS, J., MOOIBROEK, M., WONG, P. & WELSH, J. (1992) Active Cell death in hormone dependent tissues. Cancer Metastasis Rev. 11, 197-220.
39. 3 in MCF-7 breast cancer cells. In: V Vitamin D: A Pluripotent Steroid Hormone. Structural Studies, Molecular Endocrinology and Clinical Applications (edited by NORMAN, A.W., BOUILLON, R. & THOMASSET, M.), pp. 526-7. New York: Walter de Gruyter.
40. 3 results from ligand-induced stabilization. J. Biol. Chem. 267, 20082-6.
41. WYLLIE, A.H. (1987) Apoptosis: cell death in tissue regulation. J. Pathol. 153, 313-16.
42. YU, V.C., DELSERT, C., ANDERSON, B., et al. (1991) RXR-β: a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 67, 1251-66.